 |
Antibiotic
Susceptibility: Endophthalmitis
Susceptibility
of Bacterial Isolates from Endophthalmitis to Common Antibiotics
(Percent Susceptible) (1993- January 1, 2019) |
| Bacteria |
# |
VAN |
GEN |
CIP |
OFX |
CEF |
AMK |
CAZ |
METH |
AMP |
CLIN |
MOX |
| Coag-Neg
Staphylococcus |
419 |
100 |
87 |
50 |
46 |
98 |
97 |
73 |
54 |
18 |
82 |
65
(240) |
| Staphylococcus
aureus |
77 |
100 |
93 |
51 |
47 |
82 |
80 |
68 |
65 |
13 |
63 |
56
(39) |
| Streptococcus
species |
157 |
100 |
46 |
81 |
92 |
94 |
15 |
90 |
-- |
94 |
79 |
97
(95) |
| Gram-Negative
Bacteria |
58 |
12 |
95 |
93 |
92 |
32 |
96 |
95 |
-- |
32 |
10 |
92
(37) |
| Other
Gram-Positive Bacteria |
45 |
96 |
82 |
84 |
80 |
71 |
84 |
52 |
-- |
66 |
77 |
85
(26) |
| |
| * Disk diffusion susceptibilities based on CLSI/NCCLS serum standards. |
VAN=Vancomycin;
GEN=Gentamicin; CIP=Ciprofloxacin; OFX=Ofloxacin; CEF=Cefazolin;
AMK=Amikacin; CAZ=Ceftazidime; METH=Methicillin; AMP=Ampicillin;
CLIN=Clindamicin; MOX=Moxifloxacin; (--)=not done; (#) MOX= # isolates tested. |
Susceptibility*
of Gram Negative Isolates from Endophthalmitis to Common Antibiotics
(Percent Susceptible)(1993 to January 1, 2019) |
| Bacteria |
# |
GEN |
CIP |
OFX |
AMK |
CAZ |
MOX |
| Acinetobacter
lwoffii |
1 |
100 |
100 |
-- |
100 |
100 |
-- |
| Achromobacter
xylosoxidans |
1 |
0 |
100 |
100 |
0 |
100 |
-- |
| Burkholderia cepacia |
1 |
100 |
100 |
100 |
100 |
0 |
-- |
| Enterobacter aerogenes |
2 |
100 |
100 |
100 |
100 |
100 |
100 |
| Enterobacter
agglomerans |
2 |
100 |
100 |
100 |
100 |
100 |
100(1) |
| Escherichia
coli |
1 |
100 |
100 |
100 |
100 |
100 |
-- |
| Flavimonas oryzihabitans |
2 |
100 |
100 |
100(1) |
100 |
100 |
100(1) |
| Hafnia alvei |
1 |
100 |
100 |
100 |
100 |
100 |
100 |
| Haemophilus species |
8 |
88 |
100 |
100(7) |
71 |
86 |
100(4) |
| Klebsiella pneumoniae |
1 |
100 |
100 |
100 |
100 |
100 |
100 |
| Moraxella species |
4 |
100 |
100 |
100 |
100(2) |
100 |
100(2) |
| Morganella
morgannii |
4 |
75 |
37 |
67(3) |
100 |
50 |
67(3) |
| Neisseria species |
1 |
100 |
100 |
100 |
100 |
100 |
100 |
| Proteus
mirabilis |
2 |
100 |
100 |
100 |
100 |
100 |
100(1) |
| Proteus
vulgaris |
1 |
100 |
100 |
100 |
100 |
100 |
100 |
| Pseudomonas aeruginosa |
7 |
86 |
86 |
75(4) |
86 |
86 |
66(3) |
| Pseudomonas fluorescens |
1 |
100 |
100 |
100 |
100 |
100 |
100 |
| Pseudomonas putida |
1 |
100 |
100 |
100 |
100 |
100 |
100 |
| Pseudomonas
testeroni |
1 |
100 |
100 |
100 |
100 |
100 |
-- |
| Pseudomonas vesicularis |
1 |
100 |
0 |
0 |
100 |
100 |
100 |
| Ralstonia picketti |
1 |
100 |
100 |
100 |
100 |
100 |
100(1) |
| Serratia marcescens |
9 |
100 |
89 |
100 |
100 |
100 |
100(6) |
| Stenotrophomonas
maltophilia |
2 |
100 |
50 |
50 |
100 |
100 |
100(1) |
| |
| * Disk diffusion susceptibilities based on CLSI/NCCLS serum standards. |
| GEN=Gentamicin; CIP=Ciprofloxacin;
OFX=Ofloxacin; AMK=Amikacin; CAZ=Ceftazidime; MOX=Moxifloxacin; (--)=not
done; (#) for MOX= # isolates tested. |
|
|
|
